1. Home
  2. SRTS vs MYO Comparison

SRTS vs MYO Comparison

Compare SRTS & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sensus Healthcare Inc.

SRTS

Sensus Healthcare Inc.

HOLD

Current Price

$3.06

Market Cap

44.3M

Sector

Health Care

ML Signal

HOLD

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$0.98

Market Cap

44.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRTS
MYO
Founded
2010
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.3M
44.8M
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
SRTS
MYO
Price
$3.06
$0.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$7.00
$7.67
AVG Volume (30 Days)
24.5K
648.9K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,482,000.00
$1,000,000,000.00
Revenue This Year
$2.00
$9.10
Revenue Next Year
$34.23
$13.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40814.79
52 Week Low
$2.66
$0.61
52 Week High
$5.92
$2.14

Technical Indicators

Market Signals
Indicator
SRTS
MYO
Relative Strength Index (RSI) 54.06 45.95
Support Level $2.87 $0.99
Resistance Level $3.17 $1.13
Average True Range (ATR) 0.13 0.08
MACD 0.01 -0.01
Stochastic Oscillator 55.56 40.28

Price Performance

Historical Comparison
SRTS
MYO

About SRTS Sensus Healthcare Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

Share on Social Networks: